BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12370016)

  • 1. Inhibitory mechanisms of antibiotics targeting elongation factor Tu.
    Hogg T; Mesters JR; Hilgenfeld R
    Curr Protein Pept Sci; 2002 Feb; 3(1):121-31. PubMed ID: 12370016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elongation factor Tu3 (EF-Tu3) from the kirromycin producer Streptomyces ramocissimus Is resistant to three classes of EF-Tu-specific inhibitors.
    Olsthoorn-Tieleman LN; Palstra RJ; van Wezel GP; Bibb MJ; Pleij CW
    J Bacteriol; 2007 May; 189(9):3581-90. PubMed ID: 17337575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elongation factor Tu1 of the antibiotic GE2270A producer Planobispora rosea has an unexpected resistance profile against EF-Tu targeted antibiotics.
    Möhrle VG; Tieleman LN; Kraal B
    Biochem Biophys Res Commun; 1997 Jan; 230(2):320-6. PubMed ID: 9016775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum.
    Clough B; Rangachari K; Strath M; Preiser PR; Wilson RJ
    Protist; 1999 Aug; 150(2):189-95. PubMed ID: 10505418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of elongation factor Tu (EF-Tu) from different bacterial species to the antibiotics efrotomycin, pulvomycin and MDL 62879.
    Landini P; Bandera M; Soffientini A; Goldstein BP
    J Gen Microbiol; 1993 Apr; 139(4):769-74. PubMed ID: 8515234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of bacterial protein synthesis by elongation-factor-Tu-binding antibiotics MDL 62,879 and efrotomycin.
    Landini P; Bandera M; Goldstein BP; Ripamonti F; Soffientini A; Islam K; Denaro M
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):649-52. PubMed ID: 1590753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GE2270A-resistant mutations in elongation factor Tu allow productive aminoacyl-tRNA binding to EF-Tu.GTP.GE2270A complexes.
    Zuurmond AM; Martien de Graaf J; Olsthoorn-Tieleman LN; van Duyl BY; Mörhle VG; Jurnak F; Mesters JR; Hilgenfeld R; Kraal B
    J Mol Biol; 2000 Dec; 304(5):995-1005. PubMed ID: 11124042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of an EF-Tu complex with a thiazolyl peptide antibiotic determined at 2.35 A resolution: atomic basis for GE2270A inhibition of EF-Tu.
    Heffron SE; Jurnak F
    Biochemistry; 2000 Jan; 39(1):37-45. PubMed ID: 10625477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An elongation factor Tu (EF-Tu) resistant to the EF-Tu inhibitor GE2270 in the producing organism Planobispora rosea.
    Sosio M; Amati G; Cappellano C; Sarubbi E; Monti F; Donadio S
    Mol Microbiol; 1996 Oct; 22(1):43-51. PubMed ID: 8899707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the antibiotic pulvomycin on the elongation factor Tu-dependent reactions. Comparison with other antibiotics.
    Anborgh PH; Okamura S; Parmeggiani A
    Biochemistry; 2004 Dec; 43(49):15550-6. PubMed ID: 15581367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elfamycins: inhibitors of elongation factor-Tu.
    Prezioso SM; Brown NE; Goldberg JB
    Mol Microbiol; 2017 Oct; 106(1):22-34. PubMed ID: 28710887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics MDL 62,879 and kirromycin bind to distinct and independent sites of elongation factor Tu (EF-Tu).
    Landini P; Soffientini A; Monti F; Lociuro S; Marzorati E; Islam K
    Biochemistry; 1996 Dec; 35(48):15288-94. PubMed ID: 8952479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Tu elongation factors from Staphylococcus aureus and Escherichia coli: possible basis for elfamycin insensitivity.
    Hall CC; Watkins JD; Georgopapadakou NH
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2366-70. PubMed ID: 1839491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique antibiotic sensitivity of archaebacterial polypeptide elongation factors.
    Londei P; Sanz JL; Altamura S; Hummel H; Cammarano P; Amils R; Böck A; Wolf H
    J Bacteriol; 1986 Jul; 167(1):265-71. PubMed ID: 3087957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activities of chemically modified thiazolyl peptide antibiotic MDL 62,879 (GE2270A).
    Lociuro S; Tavecchia P; Marzorati E; Landini P; Goldstein BP; Denaro M; Ciabatti R
    J Antibiot (Tokyo); 1997 Apr; 50(4):344-9. PubMed ID: 9186562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
    Pingoud A; Block W; Urbanke C; Wolf H
    Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of the action of pulvomycin and GE2270 A on elongation factor Tu.
    Parmeggiani A; Krab IM; Okamura S; Nielsen RC; Nyborg J; Nissen P
    Biochemistry; 2006 Jun; 45(22):6846-57. PubMed ID: 16734421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amythiamicin D and related thiopeptides as inhibitors of the bacterial elongation factor EF-Tu: modification of the amino acid at carbon atom C2 of ring C dramatically influences activity.
    Gross S; Nguyen F; Bierschenk M; Sohmen D; Menzel T; Antes I; Wilson DN; Bach T
    ChemMedChem; 2013 Dec; 8(12):1954-62. PubMed ID: 24106106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
    Chinali G
    J Antibiot (Tokyo); 1981 Aug; 34(8):1039-45. PubMed ID: 6119303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.